Allogene Therapeutics Inc (ALLO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 51,688 | 75,218 | 83,155 | 61,904 | 173,314 |
| Marketable Securities | 198,522 | 217,258 | 365,542 | 455,416 | 283,988 |
| TOTAL | $257,749 | $303,386 | $459,115 | $528,824 | $471,323 |
| Non-Current Assets | |||||
| PPE Net | 72,839 | 86,056 | 99,478 | 112,839 | 122,990 |
| Investments And Advances | 8,043 | 80,673 | 3,645 | 76,468 | 382,378 |
| Other Non-Current Assets | 77,274 | 78,595 | 80,599 | 103,448 | 74,137 |
| TOTAL | $158,156 | $245,324 | $183,722 | $292,755 | $579,505 |
| Total Assets | $415,905 | $548,710 | $642,837 | $821,579 | $1,050,828 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,270 | 5,394 | 5,897 | 13,890 | 10,255 |
| Accrued Expenses | 28,244 | 30,129 | 31,182 | 39,743 | 37,496 |
| TOTAL | $32,514 | $35,523 | $37,079 | $53,728 | $47,907 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | 95 | 156 |
| Other Non-Current Liabilities | 90,849 | 91,008 | 93,525 | 100,969 | 77,721 |
| TOTAL | $90,849 | $91,008 | $93,525 | $100,969 | $77,721 |
| Total Liabilities | $123,363 | $126,531 | $130,604 | $154,697 | $125,628 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 243,778 | 217,265 | 169,092 | 144,497 | 142,752 |
| Common Shares | 229 | 212 | 169 | 144 | 142 |
| Retained earnings | -2,010,709 | -1,819,823 | -1,562,233 | -1,234,968 | -894,554 |
| Other shareholders' equity | 269 | -89 | -955 | -9,926 | -2,567 |
| TOTAL | $292,542 | $422,179 | $512,233 | $666,882 | $925,200 |
| Total Liabilities And Equity | $415,905 | $548,710 | $642,837 | $821,579 | $1,050,828 |